About
Prodrug therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalBiotech
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
12
As Collaborator
1
Total Enrollment
1,125
By Phase
PHASE2: 8PHASE3: 2PHASE1: 2
By Status
COMPLETED: 7RECRUITING: 2TERMINATED: 2ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06732895Lead Sponsor
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
PHASE2Recruiting
24 participants
Started: Dec 10, 2024 · Completed: Jan 31, 2027
NCT06079398Lead Sponsor
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
PHASE2Recruiting
72 participants
Started: Jan 23, 2024 · Completed: Mar 31, 2027
NCT05980598Lead Sponsor
TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma
PHASE2Terminated
27 participants
Started: Sep 29, 2023 · Completed: Mar 28, 2025
NCT05246033Lead Sponsor
A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia
PHASE2Active, not recruiting
24 participants
Started: Jan 5, 2022 · Completed: Mar 31, 2024
NCT04085523Lead Sponsor
A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia
PHASE2Completed
57 participants
Started: Jun 24, 2020 · Completed: Oct 1, 2024
Locations (1)
Headquarters
Palo Alto, CA, United States
Map
Loading map...